4:04pm ET
Investing
Rite Aid, Frontier Communications Tumble into Monday’s 52-Week Low Club
Rite Aid, Valeant, Frontier Communications, and DryShips all posted new 52-week lows on Monday.
Paul Ausick
Companies
Valeant Pharmaceuticals Intern...
$23.40
▼ $0.83 (−3.43%) today
Markets closed · 10:25pm ET
VRX Coverage
Page 4 Paul Ausick 3:45pm ET
Health and Healthcare
Why One Key Analyst Believes That Valeant Is Kicking the Can in Its Restructuring Deal
Valeant Pharmaceuticals announced that it intends to refinance some of its debt. One key analyst thinks that this might be a sign to abandon ship.
Chris Lange 9:45am ET
Health and Healthcare
Why Analysts Are Looking at Valeant Pharma Differently After Earnings
Valeant Pharmaceuticals shares hit a multiyear low this past week, and some analysts took this opportunity to reevaluate their stance on the stock.
Chris Lange 4:04pm ET
Investing
Target, Valeant Slide into Friday’s 52-Week Low Club
Target, Valeant, DryShips, and SeaDrill posted new 52-week lows on Friday.
12:05pm ET
Health and Healthcare
Why Valeant Missed the Mark Despite an Earnings Beat
Valeant Pharmaceuticals reported better-than-expected fourth-quarter financial results before the markets opened on Tuesday.
Chris Lange 10:25am ET
Investing
6 Key Earnings to Look For This Week
24/7 Wall St. has put together a preview of Valeant Pharmaceuticals, Salesforce.com and some of the other major companies reporting their quarterly results this week.
10:25am ET
Health and Healthcare
Top Biopharma Movers of the Past Week
The health care sector was in trouble over the past year, under fire from congressional hearings and politicians on the campaign trail. However things look like they could be different in 2017.
Chris Lange 11:10am ET
Health and Healthcare
Tuesday’s Top Biopharma Movers
A few biopharma companies have made massive runs on Tuesday morning.
Chris Lange 12:05pm ET
Health and Healthcare
Why This FDA Approval for Valeant Is Not as Good as First Thought
Valeant Pharmaceuticals received a key FDA approval early on Thursday, but it seems to be a mixed blessing.
3:22pm ET
Health and Healthcare
Wednesday’s Top Biopharma Movers
Biotech and pharma companies were on the move Wednesday. A few of the smaller caps made tremendous gains on the day, while a couple of the major firms saw massive volume and…
3:30pm ET
Health and Healthcare
Tuesday’s Top Biopharma Movers
Considering the new Trump administration, there is an increasingly positive sentiment in the health care sector. In the past year, the health care sector was in trouble under fire from congressional hearings…
11:05am ET
Health and Healthcare
Why Valeant Is Making a Run
Valeant Pharmaceuticals made waves early on Tuesday after the company offered announcements of a late-stage psoriasis trial and the sale of a couple business segments.
Chris Lange 9:46am ET
Investing
CEOs Who Were Fired or Forced Out in 2016: Macy’s, Wells Fargo, Valeant and More
Several high-profile CEOs lost their jobs in 2016, along with one or two who "resigned" with the cooperation of their boards.
9:45am ET
Investing
Massive Bill Ackman Trade Highlights Insider Selling: Valeant Pharmaceuticals, Starbucks, Schlumberger, Validus and More
While the selling was robust, it certainly wasn’t extraordinary, and it should be expected given the big run in the markets this year.
4:04pm ET
Investing
Valeant, HiMax Lead Thursday’s 52-Week Low Club
December 15, 2016: Here are four stocks trading with relatively heavy volume among 65 equities making new 52-week lows in Thursday’s session. On the NYSE, advancers led decliners by about 8 to…